AAAAAA
Results:
1-10
|
Results: 10
Authors:
WILS JA
VANGEUNS H
WALS J
VREESWIJK J
LALISANG F
Citation: Ja. Wils et al., EFFICACY OF CARBOPLATIN PLUS PRIMARY PROPHYLACTIC FILGRASTIM (GRANULOCYTE-COLONY-STIMULATING-FACTOR) IN RELAPSED OVARIAN-CANCER - A STUDY OF THE GYNECOLOGIC-ONCOLOGY-GROUP OF THE COMPREHENSIVE-CANCER-CENTER-LIMBURG, Anti-cancer drugs, 8(5), 1997, pp. 432-435
Authors:
LALISANG RI
WILS JA
NORTIER HW
BURGHOUTS JT
HUPPERETS PS
ERDKAMP FL
SCHOUTEN HC
BLIJHAM GH
Citation: Ri. Lalisang et al., COMPARATIVE-STUDY OF DOSE-ESCALATION VERSUS INTERVAL REDUCTION TO OBTAIN DOSE-INTENSIFICATION OF EPIRUBICIN AND CYCLOPHOSPHAMIDE WITH GRANULOCYTE-COLONY-STIMULATING FACTOR IN ADVANCED BREAST-CANCER, Journal of clinical oncology, 15(4), 1997, pp. 1367-1376
Authors:
SCHOUTEN LJ
HUPPERETS PSGJ
JAGER JJ
VOLOVICS L
WILS JA
VERBEEK ALM
BLIJHAM GH
Citation: Lj. Schouten et al., PROGNOSTIC-SIGNIFICANCE OF ETIOLOGIC RISK-FACTORS IN EARLY BREAST-CANCER, Breast cancer research and treatment, 43(3), 1997, pp. 217-223
Authors:
WYMENGA ANM
VANDERGRAAF WTA
WILS JA
VANHEUKELOM LS
VANDERLINDEN GHM
DULLEMONDWESTLAND AC
NOOY M
VANDERHEUL C
DEBRUIJN KM
DEVRIES EGE
Citation: Anm. Wymenga et al., A RANDOMIZED, DOUBLE-BLIND, MULTICENTER STUDY COMPARING DAILY 2-MG AND 5-MG OF TROPISETRON FOR THE CONTROL OF NAUSEA AND VOMITING INDUCED BY LOW-DOSE CISPLATIN-CONTAINING OR NON-CISPLATIN-CONTAINING CHEMOTHERAPY, Annals of oncology, 7(5), 1996, pp. 505-510
Authors:
WILS JA
COOMBES RC
BLISS JM
LAW M
FOUNTZILAS G
AMADORI D
ABADESTEVE A
KLEIN HO
PINTOFERREIRA E
REIS H
VASSILOPOULOS P
TRES A
WOODS E
Citation: Ja. Wils et al., PHASE I-II STUDY OF SEQUENTIAL HIGH-DOSE METHOTREXATE AND 5-FLUOROURACIL COMBINED WITH EPIRUBICIN (FEMTX) AT DIFFERENT DOSE LEVELS IN ADVANCED GASTRIC-CANCER, GI cancer, 1(1), 1995, pp. 55-59
Authors:
SCHLANGEN JT
DEBETS JMH
WILS JA
Citation: Jt. Schlangen et al., THE PINCH-OFF PHENOMENON - A RADIOLOGICAL SYMPTOM FOR POTENTIAL FRACTURE OF AN IMPLANTED PERMANENT SUBCLAVIAN CATHETER SYSTEM, European journal of radiology, 20(2), 1995, pp. 112-113
Authors:
GUASTALLA JP
VERMORKEN JB
WILS JA
GEORGE M
SCOTTO V
NOOIJ M
HUINNINK WWT
DALESIO O
RENARD J
Citation: Jp. Guastalla et al., PHASE-II TRIAL FOR INTRAPERITONEAL CISPLATIN PLUS INTRAVENOUS-SODIUM THIOSULFATE IN ADVANCED OVARIAN-CARCINOMA PATIENTS WITH MINIMAL RESIDUAL DISEASE AFTER CISPLATIN-BASED CHEMOTHERAPY - A PHASE-II STUDY OF THE EORTC GYNECOLOGICAL CANCER COOPERATIVE GROUP, European journal of cancer, 30A(1), 1994, pp. 45-49
Authors:
WAGENER DJT
DEMULDER PHM
WILS JA
Citation: Djt. Wagener et al., MULTIMODALITY TREATMENT OF LOCALLY ADVANCED PANCREATIC-CANCER, Annals of oncology, 5, 1994, pp. 190000081-190000086
Authors:
KWEE WS
WILS JA
SCHLANGEN J
ARENDS JW
Citation: Ws. Kwee et al., GASTRIC EPITHELIAL ATYPIA COMPLICATING HEPATIC ARTERIAL INFUSION CHEMOTHERAPY, Histopathology, 24(2), 1994, pp. 151-154
Authors:
WILS JA
Citation: Ja. Wils, MITOXANTRONE, LEUCOVORIN AND HIGH-DOSE INFUSIONAL 5-FLUOROURACIL - ANEFFECTIVE AND WELL-TOLERATED REGIMEN FOR THE TREATMENT OF ADVANCED BREAST-CANCER, European journal of cancer, 29A(15), 1993, pp. 2106-2108
Risultati:
1-10
|